Associate Professor Ramazan Gozukucuk has performed over 900 treatments, specialising in viral hepatitis and clinical microbiology at Hisar Hospital Intercontinental.
Dr. Nurettin Demirkol is an internal medicine specialist at Hisar Hospital Intercontinental in Istanbul. He focus on the management of hypertension, diabetes, and thyroid diseases. Dr. Demirkol holds a master’s degree in Health Management from Okan University. He has attended over 20 national medical congresses to date.
Dr Suveyda Gozukucuk is a specialist in infectious diseases at Hisar Hospital Intercontinental, focusing on hepatitis and hospital-acquired infections.
Assistant Professor Sinan Mermer is a specialist in infectious diseases at Medicalpoint International Hospital, with deep expertise in managing viral hepatitis cases.
Hepatitis C treatment in Turkey is highly effective. Modern direct-acting antiviral therapies achieve cure rates between 95% and 99%. JCI-accredited clinics in Istanbul use oral medications to eradicate the virus within 8 to 12 weeks. Leading specialists manage complex cases including cirrhosis.
Bookimed Expert Insight: Turkish clinics handle immense patient volumes. Medipol Mega University Hospital alone serves 1,000,000 patients annually. This high turnover means specialists manage varied Hepatitis C genotypes daily. Their familiarity with diverse viral strains often leads to more precise drug selection.
Patient Consensus: Patients in Turkey find the staff polite and translators very competent. They note that the process works best when clinics confirm the exact genotype before starting treatment.
Turkish clinics treat Hepatitis C using direct-acting antivirals (DAAs) like Sofosbuvir, Ledipasvir, and Daclatasvir. These medications target specific viral genotypes to reach cure rates over 95%. Specialist infectious disease units in Istanbul and Antalya provide these personalised drug regimens. Treatments usually last between 8 and 12 weeks.
Bookimed Expert Insight: Turkish clinical practice is shifting toward pan-genotypic drugs that work across all virus types. This reduces the risk of ineffective treatment if genotype testing is delayed. Patients should ask their specialist, such as Prof. Dr Ali İnal with 25 years of experience, to confirm the viral strain before starting medication cycles.
Patient Consensus: Patients note that confirming the correct genotype is vital for effective drug selection in Turkey. They often receive prescriptions for combinations like Daclatasvir and Sofosbuvir after meeting their specialist.
Modern Hepatitis C treatment in Turkey typically involves direct-acting antivirals (DAAs). These oral medications replace older interferon therapies. They generally cause only mild side effects. Common reactions include tiredness, headaches, and nausea. Most patients continue daily activities throughout the treatment without complications.
Bookimed Expert Insight: Turkish infectious disease specialists prioritise genotype-specific protocols for efficacy. Leading experts, such as Assoc. Prof. Dr. Ramazan Gozukucuk at Hisar Hospital Intercontinental, hold specialised competency certificates. This expertise helps prevent incorrect drug pairings that could lead to ineffective results.
Patient Consensus: Patients find modern Turkish treatment much easier than older regimens. Many emphasise the importance of double-checking drug interactions. Most manage to maintain their normal routines. They often note that polite staff and competent translators make the experience smoother.
Hepatitis C treatment in Turkey typically lasts 8 to 12 weeks. Specialists use oral direct-acting antiviral medicines to target the virus. Some complex cases involving cirrhosis may require up to 24 weeks. Doctors confirm a full cure with blood tests 12 weeks after finishing the medication.
Bookimed Expert Insight: Turkish infectious disease specialists often have high success rates. This is because they handle a massive volume of complex cases. For example, Hisar Hospital Intercontinental serves 250,000 patients annually. This vast experience helps doctors like Dr. Sinan Mermer tailor antiviral regimens. They can accurately match treatments for specific genotypes and co-infections.
Patient Consensus: Patients find the once-daily pill routine easy to follow. They highlight the importance of triple-checking that the drug matches their specific genotype. This is vital before purchasing expensive medication.
Patients can typically return to Australia immediately after starting Hepatitis C treatment in Turkey. Specialists prescribe daily oral medications taken for 8 to 12 weeks. Major Istanbul centres like Memorial Şişli Hospital and Anadolu Medical Center provide the initial assessment and full drug supply.
Bookimed Expert Insight: Turkey serves over 50,000 international patients annually. Major hubs like Medipol Mega University Hospital manage 1,000,000 cases. Specialists such as Assoc. Prof. Dr. Ramazan Gozukucuk at Hisar Hospital often work with international congresses on antiviral protocols. This high-volume environment helps doctors coordinate care for patients finishing treatments across borders.
Patient Consensus: Patients note the importance of waiting for genotype results for the correct drug combination. Many suggest bringing all prescriptions in hand luggage. They also recommend arranging a local Australian GP for the 12-week post-treatment blood test.
Hepatitis C diagnostics in Turkey involve specialist review, blood tests, and liver health assessments. JCI-accredited facilities in Istanbul and Antalya use PCR testing and FibroScan to confirm active infections and liver stiffness. Patients often receive results within 24 to 48 hours.
Bookimed Expert Insight: Turkish hospitals manage high patient volumes. Medipol Mega University Hospital serves 1,000,000 patients annually. Large centres often provide faster turnaround times for complex blood genetics and molecular biology tests. This speed helps international patients get accurate genotype confirmation before starting expensive antivirals.
Patient Consensus: Patients value the polite staff and competent interpreters at clinics like Memorial Antalya Hospital. They recommend getting basic PCR and genotype results before travel. This helps ensure physicians prescribe the correct medication. Providing specific genotype data avoids incorrect treatment or unnecessary costs.
Australians visiting Turkey for Hepatitis C treatment must obtain a visa. Most medical travellers use the HealthTürkiye portal to apply for a specialised medical visa. This process generally takes 7 to 10 days. Always confirm entry rules before departure as travel requirements often change.
Bookimed Expert Insight: Turkey ranks as the top global destination in our network, serving over 53,000 patients. JCI-accredited centres like Hisar Hospital Intercontinental and Memorial Şişli handle large international volumes. These hospitals often have dedicated departments to assist with documentation for medical visa applications.
Patient Consensus: Patients in Turkey highlight the importance of verifying your specific virus genotype before starting medication. Travellers appreciate the polite staff and competent translators available at centres like Memorial Antalya Hospital.